{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T02:18:21Z","timestamp":1786760301295,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Spanish \u201cMinisterio de Econom\u00eda y Competitividad\u201d","doi-asserted-by":"crossref","award":["SAF2011-26583"],"award-info":[{"award-number":["SAF2011-26583"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Autonomous Region of Madrid","award":["S2010\/BMD-2316"],"award-info":[{"award-number":["S2010\/BMD-2316"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.imbio.2016.09.002","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T16:35:17Z","timestamp":1473870917000},"page":"363-371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Extravascular hemolysis and complement consumption in Paroxysmal Nocturnal Hemoglobinuria patients undergoing eculizumab treatment"],"prefix":"10.1016","volume":"222","author":[{"given":"Marta","family":"Sub\u00edas Hidalgo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Martin Merinero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaouad","family":"Anter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila Pinto","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Ata\u00falfo Gonzalez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"For\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Lopez-Trascasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Villegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6401-1874","authenticated-orcid":false,"given":"Santiago","family":"Rodr\u00edguez de C\u00f3rdoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imbio.2016.09.002_bib0005","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/ejh.12265","article-title":"Paroxysmal Nocturnal Hemoglobinuria is rare cause for thrombosis of the intra-abdominal veins in the ethnic Indian population \u2212 results from FLAER-based flowcytometry screening","volume":"92","author":"Ahluwalia","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.imbio.2016.09.002_bib0010","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood-2007-06-094136","article-title":"Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria","volume":"111","author":"Brodsky","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2016.09.002_bib0015","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1084\/jem.164.4.1274","article-title":"Quantitative variations of the C3b\/C4b receptor (CR1) in human erythrocytes are controlled by genes within the regulator of complement activation (RCA) gene cluster","volume":"164","author":"de Cordoba","year":"1986","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2016.09.002_bib0020","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1182\/blood-2014-03-560540","article-title":"Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab","volume":"125","author":"de Latour","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2016.09.002_bib0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1939-165X.2011.00287.x","article-title":"Reference Value Advisor: a new freeware set of macroinstructions to calculate reference intervals with microsoft excel","volume":"40","author":"Geffre","year":"2011","journal-title":"Vet. Clin. Pathol."},{"key":"10.1016\/j.imbio.2016.09.002_bib0030","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3324\/haematol.2009.007229","article-title":"Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonization","volume":"95","author":"Hill","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.imbio.2016.09.002_bib0035","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa031688","article-title":"Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria","volume":"350","author":"Hillmen","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2016.09.002_bib0040","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2016.09.002_bib0045","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/gut.40.4.544","article-title":"Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality","volume":"40","author":"Homann","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.imbio.2016.09.002_bib0050","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1172\/JCI108547","article-title":"The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man","volume":"58","author":"Jaffe","year":"1976","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2016.09.002_bib0055","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1182\/blood-2011-02-333997","article-title":"Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival","volume":"117","author":"Kelly","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2016.09.002_bib0060","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.molimm.2008.09.026","article-title":"Complement Receptor 1: disease associations and therapeutic implications","volume":"46","author":"Khera","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2016.09.002_bib0065","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2015-02-625871","article-title":"Complement C3dg-mediated erythrophagocytosis: implications for paroxysmal nocturnal hemoglobinuria","volume":"126","author":"Lin","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2016.09.002_bib0070","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1172\/JCI107279","article-title":"Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells","volume":"52","author":"Logue","year":"1973","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imbio.2016.09.002_bib0075","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2011.08690.x","article-title":"Management of paroxysmal nocturnal haemoglobinuria: a personal view","volume":"153","author":"Luzzatto","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.imbio.2016.09.002_bib0080","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.imbio.2016.09.002_bib0085","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.7680492","article-title":"The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis","volume":"259","author":"Miyata","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.imbio.2016.09.002_bib0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/ejh.12346","article-title":"Paroxysmal nocturnal hemoglobinuria: a single Spanish center's experience over the last 40 yr","volume":"93","author":"Munoz-Linares","year":"2014","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.imbio.2016.09.002_bib0095","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood.V86.5.2051.bloodjournal8652051","article-title":"Proposal for a classification of the clinical stages of paroxysmal nocturnal hemoglobinuria","volume":"86","author":"Nakakuma","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2016.09.002_bib0100","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1056\/NEJMoa1311084","article-title":"Genetic variants in C5 and poor response to eculizumab","volume":"370","author":"Nishimura","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imbio.2016.09.002_bib0105","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood-2005-04-1717","article-title":"Diagnosis and management of paroxysmal nocturnal hemoglobinuria","volume":"106","author":"Parker","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2016.09.002_bib0110","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1128\/CMR.00048-09","article-title":"Infections of people with complement deficiencies and patients who have undergone splenectomy","volume":"23","author":"Ram","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.imbio.2016.09.002_bib0115","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1182\/blood-2008-11-189944","article-title":"Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab","volume":"113","author":"Risitano","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2016.09.002_bib0120","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3324\/haematol.2013.090001","article-title":"Polymorphism of the complement receptor 1 gene correlates with the hematologic response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria","volume":"99","author":"Rondelli","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.imbio.2016.09.002_bib0125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1084\/jem.155.1.96","article-title":"Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes","volume":"155","author":"Ross","year":"1982","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imbio.2016.09.002_bib0130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12185-010-0493-0","article-title":"Paroxysmal nocturnal hemoglobinuria turning Coombs-positive","volume":"91","author":"Roth","year":"2010","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.imbio.2016.09.002_bib0135","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nbt1344","article-title":"Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"25","author":"Rother","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.imbio.2016.09.002_bib0140","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0092-8674(93)90250-T","article-title":"Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria","volume":"73","author":"Takeda","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2016.09.002_bib0145","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0161-5890(96)00078-8","article-title":"Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv","volume":"33","author":"Thomas","year":"1996","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imbio.2016.09.002_bib0150","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood.V78.3.820.820","article-title":"Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum","volume":"78","author":"Wilcox","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2016.09.002_bib0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1084\/jem.164.1.50","article-title":"Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes","volume":"164","author":"Wilson","year":"1986","journal-title":"J. Exp. Med."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S017129851630362X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S017129851630362X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:43:11Z","timestamp":1759250591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S017129851630362X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S017129851630362X"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2016.09.002","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extravascular hemolysis and complement consumption in Paroxysmal Nocturnal Hemoglobinuria patients undergoing eculizumab treatment","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2016.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}